SGW
- Product code
- SGW
- Device name
- Device To Detect Antibodies To Hepatitis D Virus
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3176
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
The device to detect antibodies to hepatitis D Virus is an in vitro diagnostic device intended for prescription use for the detection of antibodies to the hepatitis D virus (anti-HDV) in human clinical specimens. The assay is intended as an aid in the diagnosis of HDV infection in individuals who are at risk for HDV infection. The assay is intended as an aid in diagnosis in conjunction with clinical findings and other diagnostic procedures. The assay is not intended for screening of blood, plasma, cells, or tissue donors.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN250032 | 2025-12-23 | DiaSorin, Inc. | LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUR… | — |
Official FDA classification page: SGW
Classification and pathway per current FDA publications. Data from openFDA (CC0).